Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Phase I Open-Label, Dose-Escalation Study of the Phosphoinositide 3-Kinase Inhibitor GSK2126458 in Subjects with Solid Tumors or Lymphoma
GSK2126458
P3K112826
NCT00972686
Solid Tumours
Phase 1
 
June 2016

Powered by ideaPoint, Inc.